Allain P, Foussard E, Boyer J
Clin Chim Acta. 1977 Jul 15;78(2):183-9. doi: 10.1016/0009-8981(77)90305-9.
The blood levels of zinc, lead, copper and albumin and the activity of erythrocyte delta-aminolevulinic acid dehydratase (ALA D), with and without addition of zinc in vitro, were measured in healthy subjects and in patients with cirrhosis. In cirrhosis there was a decrease, of zinc (-40%) albumin (-38%) and of activity of ALA D (-48%) and an increase in blood lead (+80%). Correlation between these results has been studied. The increase of blood lead is probably the result of zinc decrease. Moreover, as the urinary excretion of zinc is enhanced by chelation therapy, the prescription of zinc in lead intoxication is to be recommended. The activity of ALA D in patients with cirrhosis is less enhanced by addition of zinc in vitro than is the activity in patients intoxicated with lead. Probably in cirrhosis there is especially a decrease in the synthesis of ALA D, and lead intoxication the enzyme is inhibited.
在健康受试者和肝硬化患者中,测定了锌、铅、铜和白蛋白的血药浓度以及红细胞δ-氨基乙酰丙酸脱水酶(ALA D)的活性,体外实验分别测定了添加锌和未添加锌的情况。肝硬化患者体内锌(-40%)、白蛋白(-38%)含量降低,ALA D活性(-48%)下降,血铅含量升高(+80%)。研究了这些结果之间的相关性。血铅升高可能是锌含量降低的结果。此外,螯合疗法可增强锌的尿排泄,因此建议在铅中毒时使用锌制剂。与铅中毒患者相比,体外添加锌后,肝硬化患者体内ALA D的活性增强较少。肝硬化患者体内可能尤其存在ALA D合成减少的情况,而在铅中毒时该酶受到抑制。